Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Privia Health Group, Inc. (PRVA)
|
|
| Income Statement |
|
|
|
| Standardized | As Reported |
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 8-K | 8-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues: |
| Six Payers | 305.9 | | | 257.2 | 248.3 | 232.2 | 158.1 | 191.2 |
| Other | 107.5 | | | 85.7 | 87.2 | 81.6 | 117.2 | 60.4 |
| Revenues | 413.4 | 386.3 | 364.4 | 342.9 | 335.5 | 313.8 | 275.3 | 251.5 |
| Revenue growth [+] | 23.2% | 23.1% | 32.4% | 36.3% | 48.6% | 46.9% | 28.8% | 21.4% |
| Six Payers | 23.2% | | | 34.5% | 48.6% | 48.9% | 34.0% | 8.6% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 413.4 | 386.3 | 364.4 | 342.9 | 335.5 | 313.8 | 275.3 | 251.5 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative [+] | 32.8 | 31.2 | 33.3 | 37.3 | 37.9 | 40.8 | 43.1 | 38.5 |
| Sales and marketing | 6.0 | 5.3 | 5.2 | 5.1 | 4.8 | 4.7 | 3.8 | 4.6 |
| General and administrative | 26.8 | 26.0 | 28.2 | 32.2 | 33.1 | 36.1 | 39.3 | 33.9 |
| Other operating expenses | 371.9 | 347.0 | 327.7 | 309.0 | 301.7 | 283.5 | 250.4 | 225.4 |
| EBITDA [+] | 7.6 | 9.1 | 6.7 | -3.4 | -4.1 | -10.4 | -18.2 | -12.3 |
| EBITDA growth | -286.5% | -187.3% | -136.9% | -72.3% | -97.9% | -224.9% | -495.2% | -237.1% |
| EBITDA margin | 1.8% | 2.4% | 1.8% | -1.0% | -1.2% | -3.3% | -6.6% | -4.9% |
| Depreciation | -0.8 | 1.3 | 3.6 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| EBITA | 8.4 | 7.8 | 3.1 | -3.7 | -4.4 | -10.7 | -18.5 | -12.6 |
| EBITA margin | 2.0% | 2.0% | 0.8% | -1.1% | -1.3% | -3.4% | -6.7% | -5.0% |
| Amortization of intangibles | 1.4 | 1.0 | 0.8 | 0.8 | 0.9 | 0.8 | 0.8 | 0.2 |
| EBIT [+] | 7.0 | 6.7 | 2.2 | -4.6 | -5.3 | -11.5 | -19.3 | -12.8 |
| EBIT growth | -232.9% | -158.1% | -111.6% | -64.3% | -97.3% | -246.0% | -564.8% | -249.9% |
| EBIT margin | 1.7% | 1.7% | 0.6% | -1.3% | -1.6% | -3.7% | -7.0% | -5.1% |
| Interest income, net [+] | -0.8 | 1.8 | 1.2 | -0.3 | 0.7 | 0.2 | 0.2 | 0.3 |
| Interest expense | 0.8 | | | 0.3 | | 0.2 | 0.2 | |
| Interest income | | 1.8 | 1.2 | | 0.7 | 0.2 | 0.2 | 0.3 |
| Other income (expense), net | 1.6 | | | 0.6 | -1.3 | -0.3 | -0.2 | -0.6 |
| Pre-tax income | 7.8 | 8.5 | 3.4 | -4.3 | -5.9 | -11.8 | -19.5 | -13.1 |
| Income taxes | 1.4 | 2.1 | -13.4 | -4.8 | 5.5 | 6.3 | -7.6 | -2.2 |
| Tax rate | 18.4% | 24.9% | | 113.0% | | | 39.1% | 16.9% |
| Minority interest | -0.9 | | | -1.1 | -0.9 | -0.6 | 0.1 | -1.8 |
| Net income | 7.3 | 7.3 | 17.8 | 1.6 | -10.5 | -17.5 | -12.0 | -9.1 |
| Net margin | 1.8% | 1.9% | 4.9% | 0.5% | -3.1% | -5.6% | -4.4% | -3.6% |
| |
| Basic EPS [+] | $0.06 | $0.06 | $0.16 | $0.01 | ($0.10) | ($0.16) | ($0.12) | ($0.09) |
| Growth | -165.0% | -139.3% | -233.6% | -116.9% | -94.3% | -388.1% | -388.9% | -149.5% |
| Diluted EPS [+] | $0.06 | $0.06 | $0.14 | $0.01 | ($0.10) | ($0.16) | ($0.12) | ($0.09) |
| Growth | -160.6% | -139.3% | -223.1% | -115.1% | -94.3% | -388.1% | -388.9% | -149.5% |
| |
| Shares outstanding (basic) [+] | 116.2 | 115.0 | 114.4 | 111.6 | 108.7 | 108.1 | 103.0 | 105.9 |
| Growth | 6.9% | 6.4% | 11.1% | 5.4% | 5.8% | 12.6% | 7.3% | 10.4% |
| Shares outstanding (diluted) [+] | 124.6 | 115.0 | 124.1 | 124.8 | 108.7 | 108.1 | 103.0 | 105.9 |
| Growth | 14.6% | 6.4% | 20.6% | 17.9% | 5.8% | 12.6% | 7.3% | 10.4% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|